BioHarvest Sciences ROE 2020-2024 | BHST
Current and historical return on equity (ROE) values for BioHarvest Sciences (BHST) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| BioHarvest Sciences ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-06-30 |
$-0.02B |
$0.01B |
357.89% |
| 2024-03-31 |
$-0.02B |
$-0.00B |
237.50% |
| 2023-12-31 |
$-0.01B |
$-0.02B |
152.94% |
| 2023-09-30 |
$-0.01B |
$-0.01B |
144.00% |
| 2023-06-30 |
$-0.01B |
$-0.01B |
209.52% |
| 2023-03-31 |
$-0.01B |
$-0.01B |
250.00% |
| 2022-12-31 |
$-0.01B |
$-0.01B |
440.00% |
| 2022-09-30 |
$-0.01B |
$-0.00B |
4000.00% |
| 2022-06-30 |
$-0.01B |
$-0.00B |
-514.29% |
| 2022-03-31 |
$-0.01B |
$0.00B |
-250.00% |
| 2021-12-31 |
$-0.01B |
$0.00B |
-1000.00% |
| 2021-09-30 |
$-0.01B |
$0.00B |
4400.00% |
| 2021-06-30 |
$-0.01B |
$0.00B |
800.00% |
| 2021-03-31 |
$-0.01B |
$-0.00B |
742.86% |
| 2020-12-31 |
$-0.01B |
$-0.00B |
600.00% |
| 2020-06-30 |
$-0.00B |
$-0.00B |
400.00% |
| 2020-03-31 |
$-0.00B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
